Intelligence Platform

Patents

Browse 259 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9730989

Compositions and methods for combination therapy with dengue virus and dendritic cells

PrimeVax Immuno-Oncology · Granted Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9707221

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. · Granted Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9701946

Purification method for embryo—derived infectious bronchitis virus (IBV)

SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9689042

Use of glycolytic pathways for inhibiting or measuring oncogenic signaling

The Regents of the University of California · Granted Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 22 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663571

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9630931

Pharmaceutically active pyrazine derivatives

SENTINEL ONCOLOGY LIMITED · Granted Tue Apr 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9624228

Inhibitors of ERK and methods of use

Kura Oncology, Inc. · Granted Tue Apr 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9610352

Lyophilized viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9610309

Liquid viral formulations

ONCOLYTICS BIOTECH INC. · Granted Tue Apr 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9593163

Oncostatin M receptor antigen binding proteins

Kiniksa Pharmaceuticals, GmbH · Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9586975

Macrocyclic salt-inducible kinase inhibitors

Oncodesign SA · Granted Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9572883

Oncolytic rhabdovirus

TURNSTONE LIMITED PARTNERSHIP · Granted Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9522910

Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a p

OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYOU “FUSION PHARMA” · Granted Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9504730

Method of achieving a thymosin beta 4 concentration in a human patient

REGENERX BIOPHARMACEUTICALS, INC. · Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9408820

Broncholytic drug on the basis of prostaglandin

OBSCHESTVO S OGRANICHENNOY OTVETSTVENNOST'YU “NOXI LAB” · Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9399662

Concurrent chemotherapy and immunotherapy

The Board of Regents of the University of Texas System · Granted Tue Jul 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9370519

Macrocyclic FLT3 kinase inhibitors

Oncodesign SA · Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9365823

Virus clearance of neoplastic cells from mixed cellular compositions

ONCOLYTICS BIOTECH INC. · Granted Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9328142

Lipopeptide inhibitors of RAS oncoproteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9289408

High concentration baclofen preparations

The Board of Regents of the University of Texas System · Granted Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9241998

Methods and compositions for treatment of cancer using oncolytic RSV activity

The Board of Regents of the University of Texas System · Granted Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9198453

Methods of reducing blood lactate concentration

Stokely-Van Camp, Inc. · Granted Tue Dec 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9120967

Concentric forster resonance energy transfer relay for the parallel detection of two bio/p

United States of America as represented by the Secretary of the Air Force · Granted Tue Sep 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9107912

Methods for concomitant treatment of theophylline and febuxostat

Takeda Pharmaceuticals U.S.A., Inc. · Granted Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted